199 related articles for article (PubMed ID: 33073549)
41. Nanoparticle hardness controls the internalization pathway for drug delivery.
Li Y; Zhang X; Cao D
Nanoscale; 2015 Feb; 7(6):2758-69. PubMed ID: 25585060
[TBL] [Abstract][Full Text] [Related]
42. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
[TBL] [Abstract][Full Text] [Related]
43. Investigation of size, surface charge, PEGylation degree and concentration on the cellular uptake of polymer nanoparticles.
Ferrari R; Lupi M; Colombo C; Morbidelli M; D'Incalci M; Moscatelli D
Colloids Surf B Biointerfaces; 2014 Nov; 123():639-47. PubMed ID: 25456985
[TBL] [Abstract][Full Text] [Related]
44. C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity.
Wiersma VR; de Bruyn M; Shi C; Gooden MJ; Wouters MC; Samplonius DF; Hendriks D; Nijman HW; Wei Y; Zhou J; Helfrich W; Bremer E
MAbs; 2015; 7(2):321-30. PubMed ID: 25760768
[TBL] [Abstract][Full Text] [Related]
45. Design, Synthesis and Characterization of Novel Co-Polymers Decorated with Peptides for the Selective Nanoparticle Transport across the Cerebral Endothelium.
Falanga AP; Melone P; Cagliani R; Borbone N; D'Errico S; Piccialli G; Netti PA; Guarnieri D
Molecules; 2018 Jul; 23(7):. PubMed ID: 29986452
[TBL] [Abstract][Full Text] [Related]
46. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
47. Heuristics for the Optimal Presentation of Bioactive Peptides on Polypeptide Micelles.
Wang J; Saha S; Schaal JL; Yousefpour P; Li X; Chilkoti A
Nano Lett; 2019 Nov; 19(11):7977-7987. PubMed ID: 31642326
[TBL] [Abstract][Full Text] [Related]
48. Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.
Steinbach JM; Seo YE; Saltzman WM
Acta Biomater; 2016 Jan; 30():49-61. PubMed ID: 26602822
[TBL] [Abstract][Full Text] [Related]
49. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
50. Receptor-Mediated Enhanced Cellular Delivery of Nanoparticles Using Recombinant Receptor-Binding Domain of Diphtheria Toxin.
Agarwal M; Sahoo AK; Bose B
Mol Pharm; 2017 Jan; 14(1):23-30. PubMed ID: 27959571
[TBL] [Abstract][Full Text] [Related]
51. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer.
Xue J; Li R; Gao D; Chen F; Xie H
Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392
[TBL] [Abstract][Full Text] [Related]
52. A high-throughput bioimaging study to assess the impact of chitosan-based nanoparticle degradation on DNA delivery performance.
Gomes CP; Varela-Moreira A; Leiro V; Lopes CDF; Moreno PMD; Gomez-Lazaro M; Pêgo AP
Acta Biomater; 2016 Dec; 46():129-140. PubMed ID: 27686038
[TBL] [Abstract][Full Text] [Related]
53. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
54. Epidermal Growth Factor Enhances Cellular Uptake of Polystyrene Nanoparticles by Clathrin-Mediated Endocytosis.
Phuc LTM; Taniguchi A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629179
[TBL] [Abstract][Full Text] [Related]
55. A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy.
Alcantara KP; Malabanan JWT; Vajragupta O; Rojsitthisak P; Rojsitthisak P
J Drug Target; 2024 Jul; 32(6):587-605. PubMed ID: 38634290
[TBL] [Abstract][Full Text] [Related]
56. Unraveling the role of β1 integrin isoforms in cRGD-mediated uptake of nanoparticles bearing hydrophilized alkyne moieties in epithelial and endothelial cells.
Zhang W; Teske N; Samadi M; Sarem M; Shastri VP
Acta Biomater; 2020 Oct; 116():344-355. PubMed ID: 32871280
[TBL] [Abstract][Full Text] [Related]
57. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
[TBL] [Abstract][Full Text] [Related]
58. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
[TBL] [Abstract][Full Text] [Related]
59. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
60. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
